Sygnature Discovery appoints Louisa Jordison as Chief Financial Officer
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
The funds will be used to scale up existing operations and launch new products
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Subscribe To Our Newsletter & Stay Updated